This article is protected by copyright All rights reserved “

This article is protected by copyright. All rights reserved “
“Tumour necrosis factor (TNF), an important proinflammatory cytokine, plays a role in the regulation of cell differentiation, proliferation and death, as well as in inflammation, innate and adaptive immune responses, and also implicated in a wide variety of human diseases. The presence of DNA sequence variations in regulatory region might interfere with transcription of TNF gene, Depsipeptide cost influencing the circulating level of TNF and thus increases the susceptibility to human diseases (infectious, cancer, autoimmune, neurodegenerative and other diseases). In this review, we have comprehensively

analysed various published case–control studies of different types of human diseases, in which TNF gene polymorphism played a role, and computationally predicted several single nucleotide polymorphisms (SNPs) lie in transcription factor–binding sites (TFBS) of transcription factors (TFs). It has been observed that TNF enhancer polymorphism is implicated in several diseases, and TNF rs1800629 and rs361525 SNPs are the most important in human disease susceptibility as these might influence the transcription of TNF gene. Thirty-two SNPs lies in CDK inhibitor TFBS of 20 TFs have been detected in the TNF upstream region. It has been found that TNF enhancer polymorphism influences the serum level of TNF in different human diseases and thus affects the susceptibility to diseases. The presence

of DNA sequence variation in TNF gene causes the modification of transcriptional regulation and thus responsible for association of susceptibility/resistance with human diseases.

Tumour necrosis factor (TNF) cytokine, produced as the part of host defence against infection. This cytokine is involved in multiple inflammatory and immune responses and plays role in the pathogenesis of many autoimmune and infectious diseases. TNF gene is located on chromosome 6 in the class III region of the major histocompatibility complex (MHC) and is flanked by the lymphotoxin ‘a’ and ‘b’ genes (Fig. 1). A close linkage among HLA class I (HLA-B), class II (HLA-DR) and TNF genes has been reported [1]. TNF gene is tightly regulated at the level of transcription [2, 3]. DNA sequence variation in promoter regions of genes encoding cytokines CHIR 99021 influences susceptibility to infection and has been associated with a large number of complex human diseases. Reports indicated that polymorphism in the 5′ regulatory region of the gene has been correlated with many infectious and inflammatory diseases [4, 5]. The association of TNF rs1799964 and rs1800630 polymorphisms with advanced-stage endometriosis in the Korean population have been reported. The TNF rs1800750 polymorphism affects the binding of TF OCT-1 and alters the DNA–protein interaction. The in vitro study of TNF promoter polymorphism function was stimulated by several case–control studies of the polymorphism in relation to human disease [6].

No related posts.

Comments are closed.